| Breakdown | TTM | Oct 2025 | Oct 2024 | Oct 2023 | Oct 2022 | Oct 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 27.33B | 30.80B | 10.83B | 9.77B | 9.62B | 8.90B |
| Gross Profit | 14.01B | 13.01B | 10.84B | 10.16B | 9.62B | 8.90B |
| EBITDA | 6.37B | 5.79B | 5.06B | 0.00 | 4.73B | 4.46B |
| Net Income | 4.61B | 4.02B | 3.82B | 3.34B | 3.38B | 3.14B |
Balance Sheet | ||||||
| Total Assets | 617.73B | 576.92B | 462.23B | 423.58B | 403.74B | 355.62B |
| Cash, Cash Equivalents and Short-Term Investments | 43.43B | 33.20B | 35.75B | 39.14B | 36.34B | 36.81B |
| Total Debt | 98.78B | 149.84B | 74.78B | 53.51B | 44.88B | 43.64B |
| Total Liabilities | 584.15B | 543.15B | 436.68B | 399.90B | 381.99B | 336.94B |
| Stockholders Equity | 33.58B | 33.77B | 25.55B | 23.68B | 21.74B | 18.68B |
Cash Flow | ||||||
| Free Cash Flow | 4.61B | 4.13B | 3.95B | 4.51B | -2.59B | 5.55B |
| Operating Cash Flow | 4.97B | 4.63B | 4.65B | 5.17B | -1.92B | 9.31B |
| Investing Cash Flow | -29.80B | -7.08B | -7.34B | -80.00M | -1.46B | 1.39B |
| Financing Cash Flow | 37.06B | -1.18B | -1.10B | 19.51B | -381.00M | -1.74B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | C$159.27B | 16.58 | 11.25% | 3.61% | -4.35% | 21.22% | |
72 Outperform | C$371.23B | 17.05 | 15.95% | 2.58% | 1.99% | 22.50% | |
71 Outperform | C$77.45B | 17.05 | 13.77% | 2.64% | 6.36% | 7.80% | |
70 Outperform | C$139.11B | 13.95 | 15.24% | 3.07% | -3.32% | 27.25% | |
68 Neutral | C$137.30B | 14.57 | 11.06% | 4.32% | -5.52% | 47.19% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | C$263.97B | 17.60 | 11.85% | 3.34% | -11.69% | -11.99% |